MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Evolent Health Inc

Затворен

СекторЗдравеопазване

7.51 -4.09

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

7.51

Максимум

7.67

Ключови измерители

By Trading Economics

Приходи

14M

-51M

Продажби

-39M

444M

Марж на печалбата

-11.498

Служители

4,500

EBITDA

43M

14M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+114.21% upside

Дивиденти

By Dow Jones

Следващи печалби

6.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-256M

891M

Предишно отваряне

11.6

Предишно затваряне

7.51

Настроения в новините

By Acuity

61%

39%

306 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

Evolent Health Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.10.2025 г., 18:13 ч. UTC

Значими двигатели на пазара

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17.10.2025 г., 17:05 ч. UTC

Значими двигатели на пазара

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18.10.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18.10.2025 г., 08:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

18.10.2025 г., 07:00 ч. UTC

Печалби

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17.10.2025 г., 23:25 ч. UTC

Придобивния, сливания и поглъщания

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17.10.2025 г., 21:15 ч. UTC

Пазарно говорене

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

17.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 20:34 ч. UTC

Пазарно говорене

Deere Is Reaching the End of Its Downcycle -- Market Talk

17.10.2025 г., 20:27 ч. UTC

Пазарно говорене

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17.10.2025 г., 19:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17.10.2025 г., 19:45 ч. UTC

Пазарно говорене

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17.10.2025 г., 18:45 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17.10.2025 г., 17:44 ч. UTC

Пазарно говорене

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17.10.2025 г., 17:35 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 16:14 ч. UTC

Пазарно говорене

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17.10.2025 г., 16:04 ч. UTC

Пазарно говорене

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17.10.2025 г., 15:58 ч. UTC

Пазарно говорене

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17.10.2025 г., 15:56 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17.10.2025 г., 15:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Evolent Health Inc Прогноза

Ценова цел

By TipRanks

114.21% нагоре

12-месечна прогноза

Среден 16.13 USD  114.21%

Висок 20 USD

Нисък 9 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Evolent Health Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

11

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

10.33 / 10.95Подкрепа & съпротива

Краткосрочен план

Very Strong Bullish Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Настроение

By Acuity

306 / 371 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat